Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival

Journal of the National Cancer Institute

Volumn 106, Issue 12, 2014, Pages

  Johansson, Mattias ^a   Fanidi, Anouar ^a   Muller, David C ^a   Bassett, Julie K ^b   Midttun, Øivind ^c   Vollset, Stein Emil ^d   Travis, Ruth C ^e   Palli, Domenico ^f   Mattiello, Amalia ^g   Sieri, Sabina ^h   Trichopoulou, Antonia ^i,j   Lagiou, Pagona ^j,k,l   Trichopoulos, Dimitrios ^i,k,l   Ljungberg, Börje ^m   Hallmans, Göran ^m   Weiderpass, Elisabete ^n,o,p,q   Skeie, Guri ⁿ   González, Carlos A ^r   Dorronsoro, Miren ^s   Peeters, Petra H ^u   Bueno De Mesquita, H B ^t,u,v   Ros, Martine M ^t,v   Ruault, Marie Christine Boutron ^w,x,y   Fagherazzi, Guy ^w,x,y   Clavel, Françoise ^w,x,y   Sánchez, María José ^t,z   Gurrea, Aurelio Barricarte ^t,aa   Navarro, Carmen ^t,ab,ac   Quiros, J Ramon ^ad   Overvad, Kim ^ae   Tjønneland, Anne ^af   Aleksandrova, Krassimira ^ag   Vineis, Paolo ^ah,ai   Gunter, Marc J ^ah   Kaaks, Rudolf ^aj   Giles, Graham ^b,am   Relton, Caroline ^ak   Riboli, Elio ^ah   Boeing, Heiner ^ag   Ueland, Per Magne ^d,al   Severi, Gianluca ^b,ai,am   Brennan, Paul ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c BEVITAL AS   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ HELLENIC HEALTH FOUNDATION   (Greece)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^m UMEÅ UNIVERSITY   (Sweden)

ⁿ UNIVERSITY OF TROMSØ   (Norway)

^o CANCER REGISTRY OF NORWAY   (Norway)

^p KAROLINSKA INSTITUTE   (Sweden)

^q FOLKHÄLSAN RESEARCH CENTER   (Finland)

^r CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^s Public Health Department of Gipuzkoa   (Spain)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^v NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^w INSERM   (France)

^x CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^y INSTITUT GUSTAVE ROUSSY   (France)

^z ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^aa INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ab Regional Health Authority   (Spain)

^ac UNIVERSITY OF MURCIA   (Spain)

^ad Public Health Direc   (Spain)

^ae AARHUS UNIVERSITY   (Denmark)

^af DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^ag GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^ah IMPERIAL COLLEGE LONDON   (United Kingdom)

^ai School of Public Health and HuGeF Foundation   (Italy)

^aj GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ak NEWCASTLE UNIVERSITY   (United Kingdom)

^al HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^am UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; RIBOFLAVIN; BIOLOGICAL MARKER; CARBON; VITAMIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CARBON METABOLISM; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; HAZARD RATIO; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; BLOOD; CARCINOMA, RENAL CELL; CASE CONTROL STUDY; EUROPE; KAPLAN MEIER METHOD; KIDNEY NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK; RISK ASSESSMENT; STATISTICAL MODEL;

ADULT; AGED; BIOLOGICAL MARKERS; CARBON; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; EUROPE; FEMALE; FOLIC ACID; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RIBOFLAVIN; RISK ASSESSMENT; VITAMIN B 12; VITAMIN B 6; VITAMINS;

EID: 84922394561     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju327     Document Type: Article

References (34)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245-257.
3. Scelo G, Brennan P. The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol. 2007;4(4):205-217.
4. Purdue MP, Johansson M, Zelenika D, et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat. Genet. 2011;43(1):60-65.
5. Lee JE, Mannisto S, Spiegelman D, et al. Intakes of fruit, vegetables, and carotenoids and renal 492 cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers. 2009;18(6):1730-1739.
6. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. Aug 2008;67(3):253-256.
7. Buchner FL, Bueno-de-Mesquita HB, Linseisen J, et al. Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2010;21(3):357-371.
8. Buchner FL, Bueno-de-Mesquita HB, Ros MM, et al. Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2278-2286.
9. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51(3):267-292.
10. Lee JE, Mannisto S, Spiegelman D, et al. Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1730-1739.
11. Gibson TM, Weinstein SJ, Mayne ST, et al. A prospective study of onecarbon metabolism biomarkers and risk of renal cell carcinoma. Cancer Causes Control. 2010;21(7):1061-1069.
12. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113-1124.
13. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ. 2002;156:69-70.
14. Muller DC, Baglietto L, Manning JT, et al. Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study. Br J Cancer. 2012;107(9):1631-1636.
15. Midttun O, Hustad S, Ueland PM. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23(9):1371-1379.
16. Ueland PM, Midttun O, Windelberg A, Svardal A, Skalevik R, Hustad S. Quantitative profiling of folate and one-carbon metabolism in largescale epidemiological studies by mass spectrometry. Clin Chem Lab Med. 2007;45(12):1737-1745.
17. Midttun O, Kvalheim G, Ueland PM. High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS. Anal Bioanal Chem. 2013;405(6):2009-2017.
18. Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol. 1997;281:43-53.
19. Kelleher BP, Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol. 1991;44(7):592-595.
20. Bernaards CA, Belin TR, Schafer JL. Robustness of a multivariable normal approximation for imputation of incomplete binary data. Stat Med. 2007;26(6):1368-1382.
21. Lee KJ, Carlin JB. Multiple Imputation for Missing Data: Fully Conditional Specification Versus Multivariable Normal Imputation. Am J Epidemiol. 2010;171(5):624-632.
22. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175-2197.
23. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol. 1994;4(1):1-10.
24. Lao O, Lu TT, Nothnagel M, et al. Correlation between genetic and geographic structure in Europe. Curr Biol. 2008;18(6):1241-1248.
25. Palo JU, Ulmanen I, Lukka M, Ellonen P, Sajantila A. Genetic markers and population history: Finland revisited. Eur J Hum Genet. 2009;17(10):1336-13346.
26. Midttun O, Ulvik A, Ringdal Pedersen E, et al. Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J Nutr. 2011;141(4):611-617.
27. Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 2012;72(21):5435-5440.
28. Sakakeeny L, Roubenoff R, Obin M, et al. Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. J Nutr. 2012;142(7):1280-1285.
29. Matsubara K, Komatsu S, Oka T, Kato N. Vitamin B6-mediated suppression of colon tumorigenesis, cell proliferation, and angiogenesis (review). J Nutr Biochem. 2003;14(5):246-250.
30. Giovannucci E. Nutrient biomarkers are not always simple markers of nutrient intake. Am J Clin Nutr. 2013;97(3):657-659.
31. Cho E, Giovannucci EL, Joh HK. Nutrients related to one-carbon metabolism and risk of renal cell cancer. Cancer Causes Control. 2013;24(2):373-382.
32. Bosetti C, Scotti L, Maso LD, et al. Micronutrients and the risk of renal cell cancer: a case-control study from Italy. Cancer Causes Control. 2007;120(4):892-896.
33. Wu XY, Lu L. Vitamin b6 deficiency, genome instability and cancer. Asian Pac J Cancer Prev. 2012;13(11):5333-5338.
34. Bairoch A. The ENZYME database in 2000. Nucleic Acids Res. 2000;28(1):304-305.